For the quarter ending 2025-09-30, IBO made $18K in revenue. -$1,470K in net income. Net profit margin of -8166.67%.
| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total revenue | 18 | 7 | ||
| Cost of revenue | 1 | 11 | ||
| Sales, general and administrative compensation (inclusive of stock-based compensation) | 261 | 246 | ||
| Sales and marketing | 2 | 1 | ||
| Professional fees | 234 | 411 | ||
| Research and development | 52 | 75 | ||
| Depreciation and amortization | 288 | 288 | ||
| Rent and utilities | 19 | 18 | ||
| Other operating expenses | 109 | 110 | ||
| Total costs and expenses | 966 | 1,160 | ||
| Operating loss | -948 | -1,153 | ||
| Interest income | 3 | 3 | ||
| Change in fair value of note payable, related party | 268 | 12,942 | ||
| Interest expense | 262 | 260 | ||
| (loss) income from operations before income taxes | -1,475 | -14,352 | ||
| Income tax benefit (expense) | - | 0 | ||
| Net (loss) income | -1,475 | -14,352 | ||
| Loss from operations attributed to noncontrolling interest | -5 | -6 | ||
| Net (loss) income attributable to common stockholders | -1,470 | -14,346 | ||
| Basic | -0.12 | -1.18 | ||
| Basic | 12,185,412 | 12,185,412 | ||
| Diluted | -0.12 | -1.18 | ||
IMPACT BIOMEDICAL INC. (IBO)
IMPACT BIOMEDICAL INC. (IBO)